Fmr Llc

13F Holdings History for Celldex Therapeutics, Inc. - Common Stock, par value $0.001 (CLDX)

Symbol: CLDX on Nasdaq
Investment type: Equity / Common Stock, par value $0.001
Latest Disclosed Ownership: 4.86M shares
Security Ownership: 7.3%

Shares, Excluding Options vs Price

Value, Excluding Options

FMR LLC ownership in Celldex Therapeutics, Inc. Common Stock, par value $0.001 (CLDX)

2025-02-12 - FMR LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4.86M shares of Celldex Therapeutics, Inc. Common Stock, par value $0.001 (CLDX). This represents 7.3% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
FMR LLC	7.3%		$77.4M	4.86M			$15.94	13G/A	12/31/2024	12 Feb 2025 09:28:12

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	0.01%	+0%	$111M	5.44M	+59,027	+1.1%	$20.35	Q2 2025
3/31/2025	0.01%	+0%	$97.6M	5.38M	+522,423		$18.15	Q1 2025
12/31/2024	0.01%	0%	$123M	4.86M	-1,166,748	-19.4%	$25.27	Q4 2024
9/30/2024	0.01%	0%	$205M	6.02M	-1,804,748	-23.1%	$33.99	Q3 2024
6/30/2024	0.02%	0%	$290M	7.83M	-1,896,877	-19.5%	$37.01	Q2 2024
3/31/2024	0.03%	+0.01%	$408M	9.73M	+2,675,632	+38%	$41.97	Q1 2024
12/31/2023	0.02%	0%	$280M	7.05M	-38,711	-0.55%	$39.66	Q4 2023
9/30/2023	0.02%	+0%	$195M	7.09M	+1,250	+0.02%	$27.52	Q3 2023
6/30/2023	0.02%	+0%	$240M	7.09M	+6,792	+0.1%	$33.93	Q2 2023
3/31/2023	0.02%	+0%	$255M	7.08M	+16,104	+0.23%	$35.98	Q1 2023
12/31/2022	0.03%	+0%	$315M	7.06M	+49,131	+0.7%	$44.57	Q4 2022
9/30/2022	0.02%	+0%	$197M	7.02M	+2,699	+0.04%	$28.11	Q3 2022
6/30/2022	0.02%	+0%	$189M	7.01M	+2,891	+0.04%	$26.96	Q2 2022
3/31/2022	0.02%	+0%	$239M	7.01M	+10,673	+0.15%	$34.06	Q1 2022
12/31/2021	0.02%	+0%	$270M	7M	+1,384,247	+24.7%	$38.64	Q4 2021
9/30/2021	0.02%	+0.02%	$303M	5.62M	+5,249,039	+1433%	$53.99	Q3 2021
6/30/2021	0%	+0%	$12.2M	366K	+28,394	+8.4%	$33.44	Q2 2021
3/31/2021	0%	+0%	$6.96M	338K	+337,900	NEW	$20.60	Q1 2021
12/31/2020			$0	0	-73	-100%		Q4 2020
9/30/2020	0%		$1K	73	+73	NEW	$13.70	Q3 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.